Authors' replyBMJ 1994; 309 doi: https://doi.org/10.1136/bmj.309.6967.1512 (Published 03 December 1994) Cite this as: BMJ 1994;309:1512
- Eric S Kilpatrick,
- Alan G Rumley,
- Marek H Dominiczak,
- Michael Small
- Career registrar Principal biochemist Consultant biochemist Department of Pathological Biochemistry, Gartnavel General Hospital, Glasgow G12 0YN Consultant physician Diabetic Unit, Gartnavel General Hospital.
EDITOR,—A S Wierzbicki and colleagues think that trends in glycated haemoglobin concentration should be used with little referral to their absolute value. Accordingly, they must think that a patient with a stable haemoglobin A1c concentration of 12% should be treated in a similar manner to one with a stable value of 6%. In the light of the diabetes control and complications trial, which showed an impressive reduction in microvascular complications with improved absolute glycated haemoglobin values,1 …